The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Miller Edward since 2015.
This trader's CIK number is 1619252.
At the time of last reporting, Miller Edward was the General Counsel of Allovir, Inc.. (stock ticker symbol ALVR).
Also see all insider trading activities at Allovir, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ALXN | 0 | $0 | 1,635 | $209,576 | 0 | $0 |
| 2016 | ALXN | 0 | $0 | 1,418 | $197,741 | 0 | $0 |
| 2015 | ALXN | 0 | $0 | 366 | $65,715 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ALVR | 0 | $0 | 409 | $179 | 0 | $0 |
| 2024 | ALVR | 0 | $0 | 23,068 | $16,716 | 0 | $0 |
| 2023 | ALVR | 0 | $0 | 2,573 | $13,100 | 0 | $0 |
| 2022 | ALVR | 0 | $0 | 2,911 | $26,195 | 0 | $0 |
| 2021 | ALVR | 0 | $0 | 6,000 | $233,147 | 0 | $0 |
1. Alexion Pharmaceuticals, Inc. (ALXN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-02-27 | ALXN | Sale | 260 | 131.20 | 34,112 |
| 2017-02-28 | ALXN | Sale | 330 | 131.70 | 43,460 |
| 2017-02-06 | ALXN | Sale | 1,045 | 126.32 | 132,004 |
| 2016-09-09 | ALXN | Sale | 367 | 128.32 | 47,093 |
| 2016-02-05 | ALXN | Sale | 1,051 | 143.34 | 150,648 |
| 2015-09-09 | ALXN | Sale | 366 | 179.55 | 65,715 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-10 | ALVR | Sale | 409 | .44 | 179 |
| 2024-11-19 | ALVR | Sale | 432 | .55 | 237 |
| 2024-11-05 | ALVR | Sale | 2,272 | .86 | 1,965 |
| 2024-10-21 | ALVR | Sale | 635 | .78 | 494 |
| 2024-10-22 | ALVR | Sale | 766 | .77 | 588 |
| 2024-10-03 | ALVR | Sale | 377 | .81 | 307 |
| 2024-08-19 | ALVR | Sale | 422 | .76 | 320 |
| 2024-08-05 | ALVR | Sale | 2,323 | .73 | 1,707 |
| 2024-07-02 | ALVR | Sale | 379 | .72 | 272 |
| 2024-05-17 | ALVR | Sale | 420 | .75 | 314 |
| 2024-05-03 | ALVR | Sale | 2,311 | .80 | 1,839 |
| 2024-04-19 | ALVR | Sale | 626 | .75 | 470 |
| 2024-04-22 | ALVR | Sale | 757 | .75 | 567 |
| 2024-04-02 | ALVR | Sale | 368 | .77 | 284 |
| 2024-02-20 | ALVR | Sale | 385 | .69 | 267 |
| 2024-02-05 | ALVR | Sale | 8,869 | .67 | 5,942 |
| 2024-01-23 | ALVR | Sale | 1,302 | .67 | 873 |
| 2024-01-04 | ALVR | Sale | 424 | .64 | 270 |
| 2023-01-19 | ALVR | Sale | 2,032 | 5.08 | 10,318 |
| 2023-01-20 | ALVR | Sale | 541 | 5.14 | 2,782 |
| 2022-11-14 | ALVR | Sale | 2,358 | 8.91 | 21,019 |
| 2022-10-19 | ALVR | Sale | 553 | 9.36 | 5,176 |
| 2021-03-01 | ALVR | Sale | 6,000 | 38.86 | 233,147 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Miller Edward (General Counsel of Allovir, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.